A novel troubleshooting technique for below-the-knee artery occlusions with proximal cap ambiguity: Transpedal Retrograde Wire Just Marker Technique
CONCLUSION: Transpedal Retrograde Wire Just Marker Technique is a novel and practical technique which can be used in chronic total occlusions of below-the-knee arteries with ambiguous proximal caps.PMID:38609872 | DOI:10.1177/17085381241247101 (Source: Vascular)
Source: Vascular - April 12, 2024 Category: Surgery Authors: Ali Buturak Ersan Tatli Alper Erkin Source Type: research
A novel troubleshooting technique for below-the-knee artery occlusions with proximal cap ambiguity: Transpedal Retrograde Wire Just Marker Technique
CONCLUSION: Transpedal Retrograde Wire Just Marker Technique is a novel and practical technique which can be used in chronic total occlusions of below-the-knee arteries with ambiguous proximal caps.PMID:38609872 | DOI:10.1177/17085381241247101 (Source: Vascular)
Source: Vascular - April 12, 2024 Category: Surgery Authors: Ali Buturak Ersan Tatli Alper Erkin Source Type: research
Fubuki XF Long Sheath guide catheter use in neuroendovascular procedures: Institutional experience in 60 cases
CONCLUSION: We used Fubuki XF to safely and effectively deliver a variety of compatible neuroendovascular devices. Fubuki XF was stable in all cases and locations, and there were no device-related complications or dissections.PMID:38592015 | DOI:10.1177/15910199241245601 (Source: Interventional Neuroradiology)
Source: Interventional Neuroradiology - April 9, 2024 Category: Radiology Authors: Hamzah M Saei Samantha E Miller Holly M Pope Ameer E Hassan Source Type: research
“Evolution of Drug-Coated Devices for the Treatment of Chronic Limb Threatening Ischemia”
For patients with Chronic Limb Threatening Ischemia (CLTI), endovascular approaches to revascularization are often employed as a component of multimodality care aimed at limb preservation. However, patients with CLTI are also prone to treatment failure, particularly following balloon angioplasty alone. Drug-coated devices utilizing Paclitaxel were developed to decrease restenosis but have been primarily studied in patients presenting with claudication. In recent years, data have emerged which describe the efficacy of drug-coated devices in the treatment of patients with CLTI. (Source: Annals of Vascular Surgery)
Source: Annals of Vascular Surgery - April 4, 2024 Category: Surgery Authors: Thomas Creeden, Douglas W. Jones Source Type: research
Responses to the main critiques of the Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-2 Trial
The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 trial randomised 452 participants with chronic limb threatening ischaemia (CLTI) to either infra-inguinal surgical bypass (SB) (around 75% vein bypass [VB], 25% prosthetic) or plain balloon angioplasty (PBA). In those participants who survived for two years, randomisation to SB was associated with significantly better overall survival (OS), and a trend towards improved amputation free survival (time to death from any cause, or time to first major, above ankle, amputation, whichever occurred first, AFS) [1]. (Source: Annals of Vascular Surgery)
Source: Annals of Vascular Surgery - April 4, 2024 Category: Surgery Authors: Matthew A. Popplewell, Andrew W. Bradbury Source Type: research
Improvements in Pulmonary Artery Compliance After Balloon Pulmonary Angioplasty Depend on Baseline Pulmonary Vascular Resistance
Purpose: Chronic thromboembolic pulmonary hypertension (CTEPH) results in functional limitation from right ventricular dysfunction and ventilatory inefficiency. Treatments, including balloon pulmonary angioplasty (BPA), help by decreasing RV afterload. The afterload comprises pulmonary vascular resistance (PVR, static resistance to flow) and pulmonary artery compliance (PAC, pulsatile resistance). Patients with CTEPH and low PVR have shown both clinical and functional benefits from BPA therapy despite the low static afterload. (Source: The Journal of Heart and Lung Transplantation)
Source: The Journal of Heart and Lung Transplantation - April 1, 2024 Category: Transplant Surgery Authors: , E. Oliveros, H. Zhao, A. Vaidya, V. Lakhter, P.R. Forfia, W. Auger, R. Bashir Source Type: research
High Incidence of Pulmonary Artery Thrombosis After Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension Receiving Low-Dose Direct Oral Anticoagulants
Purpose: Chronic thromboembolic pulmonary hypertension (CTEPH) requires life-long anticoagulant therapy, whereas limited data exist on the safety and efficacy of direct oral anticoagulants (DOACs) and vitamin K antagonist (VKA) along with balloon pulmonary angioplasty (BPA). We evaluated outcomes and complications in CTEPH following BPA for individuals receiving DOACs or VKA. (Source: The Journal of Heart and Lung Transplantation)
Source: The Journal of Heart and Lung Transplantation - April 1, 2024 Category: Transplant Surgery Authors: , H. Shimokawahara, Y. Sugiyama, A. Miyagi, Y. Fukuda, M. Kanezawa, K. Suruga, K. Hayashi, S. Kobashi, M. Shigetoshi, I. Tabuchi, A. Watanabe, A. Ogawa, H. Matsubara Source Type: research
Assessment of paclitaxel drug-coated balloon angioplasty for intracranial atherosclerotic disease based on high-resolution vessel wall magnetic resonance imaging
CONCLUSIONS: The HR-VWI can accurately assess the treatment effect of DCB and robustly predict prognosis.PMID:38539050 | DOI:10.1177/15910199241239718 (Source: Interventional Neuroradiology)
Source: Interventional Neuroradiology - March 28, 2024 Category: Radiology Authors: Shu Jiang Dong Dong Kunjian Chen Chao Zhang Weiqiang Dou Xinyi Wang Source Type: research
Post-Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline
Hamostaseologie. 2024 Mar 26. doi: 10.1055/a-2229-4190. Online ahead of print.ABSTRACTIn survivors of acute pulmonary embolism (PE), the post-PE syndrome (PPES) may occur. In PPES, patients typically present with persisting or progressive dyspnea on exertion despite 3 months of therapeutic anticoagulation. Therefore, a structured follow-up is warranted to identify patients with chronic thromboembolic pulmonary disease (CTEPD) with normal pulmonary pressure or chronic thromboembolic pulmonary hypertension (CTEPH). Both are currently understood as a dual vasculopathy, that is, secondary arterio- and arteriolopathy, affecting...
Source: Hamostaseologie - March 26, 2024 Category: Hematology Authors: F Joachim Meyer Christian Opitz Source Type: research
